This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Varicella Vaccines Market

Market Insights on Varicella Vaccines covering sales outlook, demand forecast & up-to-date key trends

Varicella Vaccines Market by Product, Application, End User & Region - Forecast 2022 - 2032

Varicella Vaccines Market Outlook (2022-2032)

[305 Pages Report] The global varicella vaccines market garnered US$ 2.93 Billion in 2021, and is likely to exhibit a Y-o-Y increase of 6.1 % to be valued at US$ 3.11 Billion in 2022. The market is likely to further rise to US$ 5.76 Billion by 2032, at a projected 6.3% CAGR during the 2022-2032 forecast period.

“Rising government initiatives to curb the spread of infectious diseases, ranging from chickenpox to measles, is widening scope for varicella vaccines development, paving way for enhanced market growth prospects.”

Attributes

Details

Anticipated Base Year Value (2021)

US$ 2.93 Billion

Expected Market Value (2022)

US$ 3.11 Billion

Global Varicella Vaccines Market CAGR (2022-2032)

6.3%

Global Varicella Vaccines Market (2032)

US$ 5.76 Billion

Market Share of U.S (2021)

24.2%

Global Varicella Vaccines Market Attraction

Government initiatives to curb spread of infectious diseases has led to initiation of extensive awareness and immunization campaigns, driving market growth.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the factors propelling the global Varicella Vaccines Market?

Growing awareness regarding Vaccination and increasing acceptance of varicella vaccines

Varicella vaccines are mainly used for chickenpox, herpes zoster and mumps, measles, rubella, and varicella immunization. Chickenpox can be serious, especially in babies, adolescents, adults, pregnant women, and people with low immunity systems. Thus immunization in newborns is recommended by the World Health Organization (WHO).

Varicella Vaccines Market Download Report Brochure

Monovalent varicella vaccine and combination varicella vaccine are available to provide immunity against varicella. Increasing awareness related to the use of varicella vaccines, increasing immunization programs, and the rise in adoption of varicella vaccination worldwide also fuel the growth of the varicella vaccines market. The major factor driving the growth of the varicella vaccines market is government initiatives to increase R&D programs and immunization strategies.

What are the Factors Hampering the Global Varicella Vaccines Market?

The increasing development costs and a lower market value may impede the growth of the market in the coming years. Also, the development of vaccines is a lengthy, complicated, and expensive process as a result vaccine prices are high which may hinder the growth of the market in the forecasting period. 

Moreover, lack of awareness and poor healthcare infrastructure across developing regions is another factor affecting the industry’s expansion in the coming years.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Prevailing Opportunities in the Global Varicella Vaccines Market?

The factor that boosts the growth of the varicella vaccine is a surge in the adoption of varicella vaccination worldwide. Varicella vaccines are more efficient to build immunity against the varicella-zoster virus as the infection can cause serious diseases such as chickenpox and herpes zoster.  Immunization against these diseases is necessary as chickenpox can lead to serious complications such as bacterial infections of the skin and soft tissues in children and is also seen in adults in tropical countries like India. Increasing demand for vaccination in many countries is expected to drive the demand for the varicella vaccine market in the coming years.

As per the analysis, the chickenpox segment is anticipated to hold remunerative opportunities for the global varicella vaccines market. Various developing countries are making significant developments in their budgets, thereby, offering lucrative opportunities to players in the market. Also, various governments are initiatives in immunization programs, which is expected to increase the demand for the Varicella vaccines market.

What is the Contribution of Various Segments in Boosting the Market?

Chickenpox Immunization and Herpes Zoster Immunization to Prevail by Application

Based on application, the chickenpox immunization segment is expected to dominate the market. The segment is projected to exhibit a CAGR of 7.1% during the forecast period. Growing companies’ investment in R&D activities for gaining regulatory approvals that ensure the safety and efficacy of the vaccines coupled with increasing initiatives by manufacturers to develop new vaccines are driving the growth of this segment.

On the other hand, the herpes zoster segment is expected to experience rapid growth during the forecast period due to an increase in the geriatric population worldwide and a rising awareness regarding the use of varicella vaccines for herpes zoster. The segment is poised to document a CAGR of 6.4% across the period of assessment.

By type, Monovalent Varicella Vaccines to be deployed the Most

As per the analysis by product, the monovalent segment is expected to lead the market during the forecast period. A market valuation of US$ 2.1 Billion was anticipated, and is likely to document a value CAGR of 6.8% until 2032.

The monovalent segment is expected to grow in the forecasting period as these vaccines exhibit lesser chances of inducing febrile seizures in children compared to combination vaccines. Also, the ease of availability and presence of a large number of products are the other factors to increasing the growth of the varicella vaccines market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

What is the Regional Analysis of the Global Varicella Vaccines Market?

North America to emerge as a Key Player in the Global Market

North America is anticipated to lead the global varicella vaccines market during the forecast period. The market is likely to garner US$ 1.07 Billion while exhibiting a CAGR of 6.7% from 2022 to 2032.

The rapid development of the region can be attributed to the easy availability of varicella live vaccines and the presence of skilled healthcare experts in the region. Amongst all countries, the U.S is expected to be the most opportunistic investment landscape, with an expected market share of 24.2%.

Also, the presence of well-established healthcare infrastructure and increasing healthcare spending are boosting the growth of the overall varicella vaccines market in the region. For instance, according to the Centers for Disease Control and Prevention (CDC), in the U.S before vaccination chickenpox caused 100 deaths per year since vaccination began the rate reduced by 90% meaning fever than 20 people die from chickenpox every year.

How will Growth Opportunities unfold across the Asia Pacific?

Asia Pacific is anticipated to be one of the fastest-growing region during the forecast period. Within APAC, South Asia is expected to be the most lucrative, accounting for 10.8% market revenue, and a CAGR of 6.1% to be valued at US$ 320 Million.

East Asia is likely to be the second most lucrative, reaching US$ 270 Million. Within East Asia, China is likely to make the most significant contribution, capturing a 5.9% revenue share during the forecast period. The growth of the market can be attributed to the presence of evolving countries such as; India, China, Japan, and others. The government spending on immunization programs and changing attitudes of people towards vaccinations boost the growth of the market.

Also, the penetration of global players in the region and increasing strategic partnerships and investments by players operating in the region are expected to fuel demand for the varicella vaccines market. Increasing investments in research and development activities along with a growing number of clinical trials will provide a strong thrust to the growth of the varicella vaccines market in China positively impact the market growth.

Region-wise Market Shares for the Varicella Vaccines Market

Country

Estimated Market Share

North America

36.7%

Latin America

7.4%

Europe

26.4%

South Asia

10.8%

East Asia

9.3%

Oceania

4.5%

Middle East & Africa

4.9%

Who are the Key Players of the Global Varicella Vaccines Market?

Eminent players in the global varicella vaccines market include Bio-Med Pvt. Limited, Pfizer Inc., Emcure Pharmaceuticals Limited, Merck & Co Inc., Sanofi, and Novo Medi Sciences among others.

Recent key developments among players include:

  • In January 2022 - Pfizer Inc. and BioNTech SE announced a new research, development, and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles (herpes zoster virus, or HZV) a debilitating, disfiguring, and painful disease that impacts about one in three people in the United States during their lifetime. This is the third collaboration between Pfizer and BioNTech in the infectious diseases field.
  • In July 2021 - GC LabCell and GC Cell announced a merger agreement to combine in an all-stock transaction. The transaction brings together two iconic South Korean biopharmaceutical companies, highly complementary portfolios with a robust broad cell therapy R&D pipeline and cutting-edge manufacturing capabilities to accelerate growth and enhance value creation.
  • In December 2020 - Sanofi signed a partnership agreement with the World Health Organization (WHO), consolidating a 20-year collaboration to fight some of the most Neglected Tropical Diseases (NTDs) and supporting the WHO in its commitment to sustainably eliminate sleeping sickness before 2030. Sanofi will provide consistent financial support and dedicated disease management, including screening of populations, disease awareness campaigns, capacity building, as well as drug donation.

Key Segments Covered in the Varicella Vaccines Industry Survey

Varicella Vaccine Market by Product:

  • Monovalent Varicella Vaccines
  • Combination Varicella Vaccines

Varicella Vaccine Market by Application:

  • Varicella Vaccines for Chickenpox Immunization
  • Varicella Vaccines for Herpes Zoster Immunization
  • Varicella Vaccines for Mumps, measles, rubella & varicella (MMRV) Immunization

Varicella Vaccine Market by End User:

  • Varicella Vaccines for Hospitals
  • Varicella Vaccines for Clinics
  • Varicella Vaccines for Other End Users

Varicella Vaccine Market by Region:

  • North America Varicella Vaccines Market
  • Europe Varicella Vaccines Market
  • South Asia Varicella Vaccines Market
  • East Asia Varicella Vaccines Market
  • Oceania Varicella Vaccines Market
  • Middle East & Africa Varicella Vaccines Market
  • Latin America Varicella Vaccines Market

Frequently Asked Questions

The global varicella vaccines market was valued at US$ 2.93 Billion in 2021.

The global varicella vaccines market is estimated to grow at a CAGR of 6.3% from 2022 to 2032.

The global varicella vaccines market is predicted to procure US$ 5.76 Billion from 2022 to 2032.

The chickenpox immunization segment is projected to expand at a 7.1% CAGR during the forecast period.

Monovalent varicella vaccines are likely to exhibit a 6.8% CAGR from 2022-2032, propelling global market growth.

The U.S market is expected to account for over 24% market revenue across the coming decade.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity 

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Varicella Vaccines Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Bn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Bn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Varicella Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Bn) Analysis By Product, 2017-2021

    5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Product, 2022-2032

        5.3.1. Monovalent Vaccine

        5.3.2. Combination Vaccine

    5.4. Y-o-Y Growth Trend Analysis By Product, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Product, 2022-2032

6. Global Varicella Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Bn) Analysis By Application, 2017-2021

    6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Application, 2022-2032

        6.3.1. Chickenpox Immunization

        6.3.2. Herpes Zoster Immunization

        6.3.3. Mumps, Measles, Rubella, and VaricellaBImmunization

    6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Application, 2022-2032

7. Global Varicella Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Bn) Analysis By End User, 2017-2021

    7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By End User, 2022-2032

        7.3.1. Hospitals

        7.3.2. Clinics

        7.3.3. Others

    7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021

    7.5. Absolute $ Opportunity Analysis By End User, 2022-2032

8. Global Varicella Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2017-2021

    8.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. East Asia

        8.3.5. South Asia

        8.3.6. Oceania

        8.3.7. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Varicella Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Value (US$ Bn)ed States

            9.2.1.2. Canada

        9.2.2. By Product

        9.2.3. By Application

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By Application

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Varicella Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product

        10.2.3. By Application

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By Application

        10.3.4. By End User

    10.4. Key Takeaways

11. Europe Varicella Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. U.K.

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Product

        11.2.3. By Application

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By Application

        11.3.4. By End User

    11.4. Key Takeaways

12. East Asia Varicella Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

        12.2.2. By Product

        12.2.3. By Application

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By Application

        12.3.4. By End User

    12.4. Key Takeaways

13. South Asia Varicella Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. ASEAN

            13.2.1.3. Rest of South Asia

        13.2.2. By Product

        13.2.3. By Application

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By Application

        13.3.4. By End User

    13.4. Key Takeaways

14. Oceania Varicella Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    14.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    14.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        14.2.1. By Country

            14.2.1.1. Australia

            14.2.1.2. New Zealand

        14.2.2. By Product

        14.2.3. By Application

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By Application

        14.3.4. By End User

    14.4. Key Takeaways

15. MEA Varicella Vaccines Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    15.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    15.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Product

        15.2.3. By Application

        15.2.4. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product

        15.3.3. By Application

        15.3.4. By End User

    15.4. Key Takeaways

16. Key Countries Varicella Vaccines Market Analysis

    16.1. Value (US$ Bn)ed States

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2021

            16.1.2.1. By Product

            16.1.2.2. By Application

            16.1.2.3. By End User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2021

            16.2.2.1. By Product

            16.2.2.2. By Application

            16.2.2.3. By End User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2021

            16.3.2.1. By Product

            16.3.2.2. By Application

            16.3.2.3. By End User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2021

            16.4.2.1. By Product

            16.4.2.2. By Application

            16.4.2.3. By End User

    16.5. Rest of Latin America

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2021

            16.5.2.1. By Product

            16.5.2.2. By Application

            16.5.2.3. By End User

    16.6. Germany

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2021

            16.6.2.1. By Product

            16.6.2.2. By Application

            16.6.2.3. By End User

    16.7. U.K.

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2021

            16.7.2.1. By Product

            16.7.2.2. By Application

            16.7.2.3. By End User

    16.8. France

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2021

            16.8.2.1. By Product

            16.8.2.2. By Application

            16.8.2.3. By End User

    16.9. Spain

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2021

            16.9.2.1. By Product

            16.9.2.2. By Application

            16.9.2.3. By End User

    16.10. Italy

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2021

            16.10.2.1. By Product

            16.10.2.2. By Application

            16.10.2.3. By End User

    16.11. Rest of Europe

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2021

            16.11.2.1. By Product

            16.11.2.2. By Application

            16.11.2.3. By End User

    16.12. China

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2021

            16.12.2.1. By Product

            16.12.2.2. By Application

            16.12.2.3. By End User

    16.13. Japan

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2021

            16.13.2.1. By Product

            16.13.2.2. By Application

            16.13.2.3. By End User

    16.14. South Korea

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2021

            16.14.2.1. By Product

            16.14.2.2. By Application

            16.14.2.3. By End User

    16.15. India

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2021

            16.15.2.1. By Product

            16.15.2.2. By Application

            16.15.2.3. By End User

    16.16. ASEAN

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2021

            16.16.2.1. By Product

            16.16.2.2. By Application

            16.16.2.3. By End User

    16.17. Rest of South Asia

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2021

            16.17.2.1. By Product

            16.17.2.2. By Application

            16.17.2.3. By End User

    16.18. Australia

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2021

            16.18.2.1. By Product

            16.18.2.2. By Application

            16.18.2.3. By End User

    16.19. New Zealand

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2021

            16.19.2.1. By Product

            16.19.2.2. By Application

            16.19.2.3. By End User

    16.20. GCC Countries

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2021

            16.20.2.1. By Product

            16.20.2.2. By Application

            16.20.2.3. By End User

    16.21. South Africa

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2021

            16.21.2.1. By Product

            16.21.2.2. By Application

            16.21.2.3. By End User

    16.22. Israel

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2021

            16.22.2.1. By Product

            16.22.2.2. By Application

            16.22.2.3. By End User

    16.23. Rest of MEA

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2021

            16.23.2.1. By Product

            16.23.2.2. By Application

            16.23.2.3. By End User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product

        17.3.3. By Application

        17.3.4. By End User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. GlaxoSmithKline PLC

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Merck & Co. Inc.

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. GC Pharma (Green Cross Holdings)

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Bio-Med Pvt Ltd

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. Novo Medi Sciences Pvt Ltd

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Takeda Pharmaceutical Company Limited

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Mitsubishi Tanabe Pharma Corporation

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Sinovac Biotech Ltd.

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Changchun Keygen Biological Products Co.,Ltd (CNBG Subsidiary)

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. Sinergium Biotech

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

        18.1.11. SK Bioscience Co., Ltd.

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Varicella Vaccines Market Value (US$ Bn) Forecast by Region, 2017-2032

Table 2: Global Varicella Vaccines Market Value (US$ Bn) Forecast by Product, 2017-2032

Table 3: Global Varicella Vaccines Market Value (US$ Bn) Forecast by Application, 2017-2032

Table 4: Global Varicella Vaccines Market Value (US$ Bn) Forecast by End User, 2017-2032

Table 5: North America Varicella Vaccines Market Value (US$ Bn) Forecast by Country, 2017-2032

Table 6: North America Varicella Vaccines Market Value (US$ Bn) Forecast by Product, 2017-2032

Table 7: North America Varicella Vaccines Market Value (US$ Bn) Forecast by Application, 2017-2032

Table 8: North America Varicella Vaccines Market Value (US$ Bn) Forecast by End User, 2017-2032

Table 9: Latin America Varicella Vaccines Market Value (US$ Bn) Forecast by Country, 2017-2032

Table 10: Latin America Varicella Vaccines Market Value (US$ Bn) Forecast by Product, 2017-2032

Table 11: Latin America Varicella Vaccines Market Value (US$ Bn) Forecast by Application, 2017-2032

Table 12: Latin America Varicella Vaccines Market Value (US$ Bn) Forecast by End User, 2017-2032

Table 13: Europe Varicella Vaccines Market Value (US$ Bn) Forecast by Country, 2017-2032

Table 14: Europe Varicella Vaccines Market Value (US$ Bn) Forecast by Product, 2017-2032

Table 15: Europe Varicella Vaccines Market Value (US$ Bn) Forecast by Application, 2017-2032

Table 16: Europe Varicella Vaccines Market Value (US$ Bn) Forecast by End User, 2017-2032

Table 17: East Asia Varicella Vaccines Market Value (US$ Bn) Forecast by Country, 2017-2032

Table 18: East Asia Varicella Vaccines Market Value (US$ Bn) Forecast by Product, 2017-2032

Table 19: East Asia Varicella Vaccines Market Value (US$ Bn) Forecast by Application, 2017-2032

Table 20: East Asia Varicella Vaccines Market Value (US$ Bn) Forecast by End User, 2017-2032

Table 21: South Asia Varicella Vaccines Market Value (US$ Bn) Forecast by Country, 2017-2032

Table 22: South Asia Varicella Vaccines Market Value (US$ Bn) Forecast by Product, 2017-2032

Table 23: South Asia Varicella Vaccines Market Value (US$ Bn) Forecast by Application, 2017-2032

Table 24: South Asia Varicella Vaccines Market Value (US$ Bn) Forecast by End User, 2017-2032

Table 25: Oceania Varicella Vaccines Market Value (US$ Bn) Forecast by Country, 2017-2032

Table 26: Oceania Varicella Vaccines Market Value (US$ Bn) Forecast by Product, 2017-2032

Table 27: Oceania Varicella Vaccines Market Value (US$ Bn) Forecast by Application, 2017-2032

Table 28: Oceania Varicella Vaccines Market Value (US$ Bn) Forecast by End User, 2017-2032

Table 29: MEA Varicella Vaccines Market Value (US$ Bn) Forecast by Country, 2017-2032

Table 30: MEA Varicella Vaccines Market Value (US$ Bn) Forecast by Product, 2017-2032

Table 31: MEA Varicella Vaccines Market Value (US$ Bn) Forecast by Application, 2017-2032

Table 32: MEA Varicella Vaccines Market Value (US$ Bn) Forecast by End User, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Global Varicella Vaccines Market Value (US$ Bn) by Product, 2022-2032

Figure 2: Global Varicella Vaccines Market Value (US$ Bn) by Application, 2022-2032

Figure 3: Global Varicella Vaccines Market Value (US$ Bn) by End User, 2022-2032

Figure 4: Global Varicella Vaccines Market Value (US$ Bn) by Region, 2022-2032

Figure 5: Global Varicella Vaccines Market Value (US$ Bn) Analysis by Region, 2017-2032

Figure 6: Global Varicella Vaccines Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 7: Global Varicella Vaccines Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 8: Global Varicella Vaccines Market Value (US$ Bn) Analysis by Product, 2017-2032

Figure 9: Global Varicella Vaccines Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 10: Global Varicella Vaccines Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 11: Global Varicella Vaccines Market Value (US$ Bn) Analysis by Application, 2017-2032

Figure 12: Global Varicella Vaccines Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 13: Global Varicella Vaccines Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 14: Global Varicella Vaccines Market Value (US$ Bn) Analysis by End User, 2017-2032

Figure 15: Global Varicella Vaccines Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 16: Global Varicella Vaccines Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 17: Global Varicella Vaccines Market Attractiveness by Product, 2022-2032

Figure 18: Global Varicella Vaccines Market Attractiveness by Application, 2022-2032

Figure 19: Global Varicella Vaccines Market Attractiveness by End User, 2022-2032

Figure 20: Global Varicella Vaccines Market Attractiveness by Region, 2022-2032

Figure 21: North America Varicella Vaccines Market Value (US$ Bn) by Product, 2022-2032

Figure 22: North America Varicella Vaccines Market Value (US$ Bn) by Application, 2022-2032

Figure 23: North America Varicella Vaccines Market Value (US$ Bn) by End User, 2022-2032

Figure 24: North America Varicella Vaccines Market Value (US$ Bn) by Country, 2022-2032

Figure 25: North America Varicella Vaccines Market Value (US$ Bn) Analysis by Country, 2017-2032

Figure 26: North America Varicella Vaccines Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 27: North America Varicella Vaccines Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 28: North America Varicella Vaccines Market Value (US$ Bn) Analysis by Product, 2017-2032

Figure 29: North America Varicella Vaccines Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 30: North America Varicella Vaccines Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 31: North America Varicella Vaccines Market Value (US$ Bn) Analysis by Application, 2017-2032

Figure 32: North America Varicella Vaccines Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 33: North America Varicella Vaccines Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 34: North America Varicella Vaccines Market Value (US$ Bn) Analysis by End User, 2017-2032

Figure 35: North America Varicella Vaccines Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 36: North America Varicella Vaccines Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 37: North America Varicella Vaccines Market Attractiveness by Product, 2022-2032

Figure 38: North America Varicella Vaccines Market Attractiveness by Application, 2022-2032

Figure 39: North America Varicella Vaccines Market Attractiveness by End User, 2022-2032

Figure 40: North America Varicella Vaccines Market Attractiveness by Country, 2022-2032

Figure 41: Latin America Varicella Vaccines Market Value (US$ Bn) by Product, 2022-2032

Figure 42: Latin America Varicella Vaccines Market Value (US$ Bn) by Application, 2022-2032

Figure 43: Latin America Varicella Vaccines Market Value (US$ Bn) by End User, 2022-2032

Figure 44: Latin America Varicella Vaccines Market Value (US$ Bn) by Country, 2022-2032

Figure 45: Latin America Varicella Vaccines Market Value (US$ Bn) Analysis by Country, 2017-2032

Figure 46: Latin America Varicella Vaccines Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 47: Latin America Varicella Vaccines Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 48: Latin America Varicella Vaccines Market Value (US$ Bn) Analysis by Product, 2017-2032

Figure 49: Latin America Varicella Vaccines Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 50: Latin America Varicella Vaccines Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 51: Latin America Varicella Vaccines Market Value (US$ Bn) Analysis by Application, 2017-2032

Figure 52: Latin America Varicella Vaccines Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 53: Latin America Varicella Vaccines Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 54: Latin America Varicella Vaccines Market Value (US$ Bn) Analysis by End User, 2017-2032

Figure 55: Latin America Varicella Vaccines Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 56: Latin America Varicella Vaccines Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 57: Latin America Varicella Vaccines Market Attractiveness by Product, 2022-2032

Figure 58: Latin America Varicella Vaccines Market Attractiveness by Application, 2022-2032

Figure 59: Latin America Varicella Vaccines Market Attractiveness by End User, 2022-2032

Figure 60: Latin America Varicella Vaccines Market Attractiveness by Country, 2022-2032

Figure 61: Europe Varicella Vaccines Market Value (US$ Bn) by Product, 2022-2032

Figure 62: Europe Varicella Vaccines Market Value (US$ Bn) by Application, 2022-2032

Figure 63: Europe Varicella Vaccines Market Value (US$ Bn) by End User, 2022-2032

Figure 64: Europe Varicella Vaccines Market Value (US$ Bn) by Country, 2022-2032

Figure 65: Europe Varicella Vaccines Market Value (US$ Bn) Analysis by Country, 2017-2032

Figure 66: Europe Varicella Vaccines Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 67: Europe Varicella Vaccines Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 68: Europe Varicella Vaccines Market Value (US$ Bn) Analysis by Product, 2017-2032

Figure 69: Europe Varicella Vaccines Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 70: Europe Varicella Vaccines Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 71: Europe Varicella Vaccines Market Value (US$ Bn) Analysis by Application, 2017-2032

Figure 72: Europe Varicella Vaccines Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 73: Europe Varicella Vaccines Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 74: Europe Varicella Vaccines Market Value (US$ Bn) Analysis by End User, 2017-2032

Figure 75: Europe Varicella Vaccines Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 76: Europe Varicella Vaccines Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 77: Europe Varicella Vaccines Market Attractiveness by Product, 2022-2032

Figure 78: Europe Varicella Vaccines Market Attractiveness by Application, 2022-2032

Figure 79: Europe Varicella Vaccines Market Attractiveness by End User, 2022-2032

Figure 80: Europe Varicella Vaccines Market Attractiveness by Country, 2022-2032

Figure 81: East Asia Varicella Vaccines Market Value (US$ Bn) by Product, 2022-2032

Figure 82: East Asia Varicella Vaccines Market Value (US$ Bn) by Application, 2022-2032

Figure 83: East Asia Varicella Vaccines Market Value (US$ Bn) by End User, 2022-2032

Figure 84: East Asia Varicella Vaccines Market Value (US$ Bn) by Country, 2022-2032

Figure 85: East Asia Varicella Vaccines Market Value (US$ Bn) Analysis by Country, 2017-2032

Figure 86: East Asia Varicella Vaccines Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 87: East Asia Varicella Vaccines Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 88: East Asia Varicella Vaccines Market Value (US$ Bn) Analysis by Product, 2017-2032

Figure 89: East Asia Varicella Vaccines Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 90: East Asia Varicella Vaccines Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 91: East Asia Varicella Vaccines Market Value (US$ Bn) Analysis by Application, 2017-2032

Figure 92: East Asia Varicella Vaccines Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 93: East Asia Varicella Vaccines Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 94: East Asia Varicella Vaccines Market Value (US$ Bn) Analysis by End User, 2017-2032

Figure 95: East Asia Varicella Vaccines Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 96: East Asia Varicella Vaccines Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 97: East Asia Varicella Vaccines Market Attractiveness by Product, 2022-2032

Figure 98: East Asia Varicella Vaccines Market Attractiveness by Application, 2022-2032

Figure 99: East Asia Varicella Vaccines Market Attractiveness by End User, 2022-2032

Figure 100: East Asia Varicella Vaccines Market Attractiveness by Country, 2022-2032

Figure 101: South Asia Varicella Vaccines Market Value (US$ Bn) by Product, 2022-2032

Figure 102: South Asia Varicella Vaccines Market Value (US$ Bn) by Application, 2022-2032

Figure 103: South Asia Varicella Vaccines Market Value (US$ Bn) by End User, 2022-2032

Figure 104: South Asia Varicella Vaccines Market Value (US$ Bn) by Country, 2022-2032

Figure 105: South Asia Varicella Vaccines Market Value (US$ Bn) Analysis by Country, 2017-2032

Figure 106: South Asia Varicella Vaccines Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 107: South Asia Varicella Vaccines Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 108: South Asia Varicella Vaccines Market Value (US$ Bn) Analysis by Product, 2017-2032

Figure 109: South Asia Varicella Vaccines Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 110: South Asia Varicella Vaccines Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 111: South Asia Varicella Vaccines Market Value (US$ Bn) Analysis by Application, 2017-2032

Figure 112: South Asia Varicella Vaccines Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 113: South Asia Varicella Vaccines Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 114: South Asia Varicella Vaccines Market Value (US$ Bn) Analysis by End User, 2017-2032

Figure 115: South Asia Varicella Vaccines Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 116: South Asia Varicella Vaccines Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 117: South Asia Varicella Vaccines Market Attractiveness by Product, 2022-2032

Figure 118: South Asia Varicella Vaccines Market Attractiveness by Application, 2022-2032

Figure 119: South Asia Varicella Vaccines Market Attractiveness by End User, 2022-2032

Figure 120: South Asia Varicella Vaccines Market Attractiveness by Country, 2022-2032

Figure 121: Oceania Varicella Vaccines Market Value (US$ Bn) by Product, 2022-2032

Figure 122: Oceania Varicella Vaccines Market Value (US$ Bn) by Application, 2022-2032

Figure 123: Oceania Varicella Vaccines Market Value (US$ Bn) by End User, 2022-2032

Figure 124: Oceania Varicella Vaccines Market Value (US$ Bn) by Country, 2022-2032

Figure 125: Oceania Varicella Vaccines Market Value (US$ Bn) Analysis by Country, 2017-2032

Figure 126: Oceania Varicella Vaccines Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 127: Oceania Varicella Vaccines Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 128: Oceania Varicella Vaccines Market Value (US$ Bn) Analysis by Product, 2017-2032

Figure 129: Oceania Varicella Vaccines Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 130: Oceania Varicella Vaccines Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 131: Oceania Varicella Vaccines Market Value (US$ Bn) Analysis by Application, 2017-2032

Figure 132: Oceania Varicella Vaccines Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 133: Oceania Varicella Vaccines Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 134: Oceania Varicella Vaccines Market Value (US$ Bn) Analysis by End User, 2017-2032

Figure 135: Oceania Varicella Vaccines Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 136: Oceania Varicella Vaccines Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 137: Oceania Varicella Vaccines Market Attractiveness by Product, 2022-2032

Figure 138: Oceania Varicella Vaccines Market Attractiveness by Application, 2022-2032

Figure 139: Oceania Varicella Vaccines Market Attractiveness by End User, 2022-2032

Figure 140: Oceania Varicella Vaccines Market Attractiveness by Country, 2022-2032

Figure 141: MEA Varicella Vaccines Market Value (US$ Bn) by Product, 2022-2032

Figure 142: MEA Varicella Vaccines Market Value (US$ Bn) by Application, 2022-2032

Figure 143: MEA Varicella Vaccines Market Value (US$ Bn) by End User, 2022-2032

Figure 144: MEA Varicella Vaccines Market Value (US$ Bn) by Country, 2022-2032

Figure 145: MEA Varicella Vaccines Market Value (US$ Bn) Analysis by Country, 2017-2032

Figure 146: MEA Varicella Vaccines Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 147: MEA Varicella Vaccines Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 148: MEA Varicella Vaccines Market Value (US$ Bn) Analysis by Product, 2017-2032

Figure 149: MEA Varicella Vaccines Market Value Share (%) and BPS Analysis by Product, 2022-2032

Figure 150: MEA Varicella Vaccines Market Y-o-Y Growth (%) Projections by Product, 2022-2032

Figure 151: MEA Varicella Vaccines Market Value (US$ Bn) Analysis by Application, 2017-2032

Figure 152: MEA Varicella Vaccines Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 153: MEA Varicella Vaccines Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 154: MEA Varicella Vaccines Market Value (US$ Bn) Analysis by End User, 2017-2032

Figure 155: MEA Varicella Vaccines Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 156: MEA Varicella Vaccines Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 157: MEA Varicella Vaccines Market Attractiveness by Product, 2022-2032

Figure 158: MEA Varicella Vaccines Market Attractiveness by Application, 2022-2032

Figure 159: MEA Varicella Vaccines Market Attractiveness by End User, 2022-2032

Figure 160: MEA Varicella Vaccines Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Pneumococcal Vaccines Market

Published : September 2021

Healthcare

Halal Nutraceuticals & Vaccines Market

Published : July 2021

Healthcare

Dengue Vaccines Market

Published : April 2021

Healthcare

Veterinary Vaccines Market

Published : February 2022

Google translate

Varicella Vaccines Market